CDSCO Circular New Drugs Division NDCT Rules 2019 Formulation Intermediates Modified Release 24 June 2026 ⚠ Regulatory Action — Immediate Attention Required All manufacturers and importers of formulation intermediates including SR/ER/PR/DR pellets, directly compressible granules, taste-masked granules, and modified release…
Ethics Committee is a body responsible for ensuring that medical experimentation and human subject research are carried out in an ethical manner in accordance with national and international laws. Central Drugs Standard Control Organization, the national drug regulatory authority has…
Recent Post
- CDSCO Notifies Final Guidance Document on Medical Device Software (MDSW)
- When a “+” Sign Isn’t Just a Plus
- DCC intends to tighten control on manufacturing and supply of printed packaging materials used for drugs
- High-Alcohol Oral Formulations Move Into Schedule H1
- DCC Recommends Comprehensive Regulatory Mechanism to Curb Unapproved Drugs and FDCs
